These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20236705)

  • 1. Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid.
    Thompson J; Lorber M; Toms LL; Kato K; Calafat AM; Mueller JF
    Environ Int; 2010 May; 36(4):390-397. PubMed ID: 20236705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.
    Li Y; Fletcher T; Mucs D; Scott K; Lindh CH; Tallving P; Jakobsson K
    Occup Environ Med; 2018 Jan; 75(1):46-51. PubMed ID: 29133598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical human exposure to perfluoroalkyl acids in the United States and Australia reconstructed from biomonitoring data using population-based pharmacokinetic modelling.
    Gomis MI; Vestergren R; MacLeod M; Mueller JF; Cousins IT
    Environ Int; 2017 Nov; 108():92-102. PubMed ID: 28818713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between perfluorooctanoate and perfluorooctane sulfonate blood concentrations in the general population and routine drinking water exposure.
    Zhang S; Kang Q; Peng H; Ding M; Zhao F; Zhou Y; Dong Z; Zhang H; Yang M; Tao S; Hu J
    Environ Int; 2019 May; 126():54-60. PubMed ID: 30776750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.
    Hsu JY; Hsu JF; Ho HH; Chiang CF; Liao PC
    Chemosphere; 2013 Sep; 93(3):532-7. PubMed ID: 23886440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of perfluorooctane sulfonate and perfluorooctane acid in serum of non-occupational human from Shenyang and Chongqing areas].
    Jin YH; Dong GH; Shu WQ; Ding M; Zhai C; Wang L; Liu X; Saitou N; Sasaki K
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):560-3. PubMed ID: 17086703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue bioaccumulation patterns, xenobiotic biotransformation and steroid hormone levels in Atlantic salmon (Salmo salar) fed a diet containing perfluoroactane sulfonic or perfluorooctane carboxylic acids.
    Mortensen AS; Letcher RJ; Cangialosi MV; Chu S; Arukwe A
    Chemosphere; 2011 May; 83(8):1035-44. PubMed ID: 21354591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorinated compounds in human blood, water, edible freshwater fish, and seafood in China: daily intake and regional differences in human exposures.
    Zhang T; Sun H; Lin Y; Wang L; Zhang X; Liu Y; Geng X; Zhao L; Li F; Kannan K
    J Agric Food Chem; 2011 Oct; 59(20):11168-76. PubMed ID: 21928843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating consumer exposure to PFOS and PFOA.
    Trudel D; Horowitz L; Wormuth M; Scheringer M; Cousins IT; Hungerbühler K
    Risk Anal; 2008 Apr; 28(2):251-69. PubMed ID: 18419647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children's exposure to perfluoroalkyl acids - a modelling approach.
    Balk FGP; Winkens Pütz K; Ribbenstedt A; Gomis MI; Filipovic M; Cousins IT
    Environ Sci Process Impacts; 2019 Nov; 21(11):1875-1886. PubMed ID: 31549993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: preliminary results of the PREVIENI project.
    La Rocca C; Alessi E; Bergamasco B; Caserta D; Ciardo F; Fanello E; Focardi S; Guerranti C; Stecca L; Moscarini M; Perra G; Tait S; Zaghi C; Mantovani A
    Int J Hyg Environ Health; 2012 Feb; 215(2):206-11. PubMed ID: 22197512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years.
    Harada K; Saito N; Inoue K; Yoshinaga T; Watanabe T; Sasaki S; Kamiyama S; Koizumi A
    J Occup Health; 2004 Mar; 46(2):141-7. PubMed ID: 15090689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, gender and region on serum concentrations of perfluorinated compounds in general population of Henan, China.
    Fu Y; Wang T; Wang P; Fu Q; Lu Y
    Chemosphere; 2014 Sep; 110():104-10. PubMed ID: 24630253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.
    Fàbrega F; Nadal M; Schuhmacher M; Domingo JL; Kumar V
    Regul Toxicol Pharmacol; 2016 Jun; 77():230-9. PubMed ID: 26993749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.
    Midasch O; Schettgen T; Angerer J
    Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study.
    Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF
    Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of perfluorinated substances in an adult German population in southern Bavaria.
    Fromme H; Midasch O; Twardella D; Angerer J; Boehmer S; Liebl B
    Int Arch Occup Environ Health; 2007 Feb; 80(4):313-9. PubMed ID: 16915390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ongoing blood loss on human serum concentrations of perfluorinated acids.
    Lorber M; Eaglesham GE; Hobson P; Toms LM; Mueller JF; Thompson JS
    Chemosphere; 2015 Jan; 118():170-7. PubMed ID: 25180653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.